# Efficacy and Safety of HE10 for Dry Eye Syndrome

> **NCT02492412** · PHASE3 · COMPLETED · sponsor: **Huons Co., Ltd.** · enrollment: 101 (actual)

## Conditions studied

- Dry Eye Syndrome

## Interventions

- **DRUG:** HE 10
- **DRUG:** Restasis

## Key facts

- **NCT ID:** NCT02492412
- **Lead sponsor:** Huons Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2014-07
- **Final completion:** 2014-09
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2015-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02492412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02492412, "Efficacy and Safety of HE10 for Dry Eye Syndrome". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT02492412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*